Jim Tananbaum was recently delighted to add a new staff to his team at Foresite Capital, Dr. Molly He. The able doctor joined the firm as a Venture Partner. She possesses enough knowledge in pharmaceutical and genomic research and development drawn from over 15 years of working in the sector. She has cut a niche in next-generation sequencing as a scientific researcher to emulate. She boasts over 20 patents in the industry. Dr. Molly He is an ex-student of the University of California and Nankai University where she attained a Ph.D. in protein biophysics and a Bachelor’s degree in biochemistry respectively.
Dr. Molly He began her career in the pharmaceutical industry. For ten years, she developed cancer and immune diseases antibodies and drugs. Prior to joining Foresite Capital, Dr. Molly He was a senior director of scientific research at Illumina. She was mandated to oversee the worldwide creation and development of protein reagent for the company. She had previously worked for Pacific Biosciences where she headed the protein sciences. She was in charge of the firm’s real-time sequencing chemistry, overseeing the development of protein reagent.
Dr. Molly is An Invaluable Addition
Having held senior positions in her career journey, Dr. Molly He’s leadership qualities are unmatched. Knowing this, the Managing Director at Foresite Capital, Jim Tananbaum (https://www.linkedin.com/in/jim-tananbaum-a7562a7/), was confident that the team had gained a resourceful member. Dr. Molly He was equally enthusiastic about joining the team at Foresite Capital. She demonstrated her readiness to play a part in the growth of the company’s next-generation sequencing agenda.
Foresite Capital is a San Francisco-based firm that helps upcoming leaders in healthcare gain the much-needed capital to grow. Foresite also has a satellite office in New York. The main focus of the firm are investors dealing with disruptive products and services.
Jim Tananbaum is a central figure in the healthcare sector in the United States. Prior to founding Foresite Capital, he worked for Prospect Venture Partners, Theravance, Sierra Ventures, and GelTex.
Jim Tananbaum attended the Yale University for his math and computer science course. He also pursued further education the well-known MIT and the highly reputable Harvard Medical School. View his profile on Bloomberg.